1. Home
  2. PRPO vs LIDR Comparison

PRPO vs LIDR Comparison

Compare PRPO & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • LIDR
  • Stock Information
  • Founded
  • PRPO N/A
  • LIDR 2013
  • Country
  • PRPO United States
  • LIDR United States
  • Employees
  • PRPO N/A
  • LIDR N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • LIDR Auto Parts:O.E.M.
  • Sector
  • PRPO Industrials
  • LIDR Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • PRPO 9.5M
  • LIDR 10.2M
  • IPO Year
  • PRPO N/A
  • LIDR N/A
  • Fundamental
  • Price
  • PRPO $6.25
  • LIDR $1.02
  • Analyst Decision
  • PRPO
  • LIDR Hold
  • Analyst Count
  • PRPO 0
  • LIDR 1
  • Target Price
  • PRPO N/A
  • LIDR N/A
  • AVG Volume (30 Days)
  • PRPO 7.5K
  • LIDR 117.8K
  • Earning Date
  • PRPO 11-06-2024
  • LIDR 11-12-2024
  • Dividend Yield
  • PRPO N/A
  • LIDR N/A
  • EPS Growth
  • PRPO N/A
  • LIDR N/A
  • EPS
  • PRPO N/A
  • LIDR N/A
  • Revenue
  • PRPO $17,411,000.00
  • LIDR $225,000.00
  • Revenue This Year
  • PRPO $75.18
  • LIDR N/A
  • Revenue Next Year
  • PRPO N/A
  • LIDR $2,650.00
  • P/E Ratio
  • PRPO N/A
  • LIDR N/A
  • Revenue Growth
  • PRPO 31.31
  • LIDR N/A
  • 52 Week Low
  • PRPO $4.31
  • LIDR $0.92
  • 52 Week High
  • PRPO $8.49
  • LIDR $5.37
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 52.41
  • LIDR 41.73
  • Support Level
  • PRPO $6.14
  • LIDR $0.96
  • Resistance Level
  • PRPO $6.47
  • LIDR $1.25
  • Average True Range (ATR)
  • PRPO 0.19
  • LIDR 0.09
  • MACD
  • PRPO 0.01
  • LIDR -0.00
  • Stochastic Oscillator
  • PRPO 88.00
  • LIDR 31.03

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: